广东明珠集团股份有限公司 2025 年第三次临时股东会会议资料 二〇二五年十二月十八日 广东明珠集团股份有限公司 2025 年第三次临时股东会会议资料 广东明珠集团股份有限公司 网络投票起止时间：自 2025 年 12 月 18 日 至 2025 年 12 月 18 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东会召开当日的 9:15-15:00。 现场会议： 时间：2025 年 12 月 18 日 14 点 00 分 地点：广东省兴宁市官汕路 99 号本公司技术中心大楼二楼会议室 议程： 2025 年第三次临时股东会议程 网络投票： 网络投票系统：上海证券交易所股东会网络投票系统 一、与会人员签到，领取会议资料；股东及股东代理人同时递交身份证明材 料（授权委托书、营业执照复印件、身份证复印件等）并领取《表决票》； 二、董事长宣布会议开始； 三、董事会秘书宣布股东登记情况及出席本次股东会的股东及代理人持股情 况；宣读表决办法及参会须知； 四、董事长提请股 ...

Group 1 - The steel raw materials sector increased by 1.62% on December 8, with Dazhong Mining leading the gains [1] - The Shanghai Composite Index closed at 3924.08, up 0.54%, while the Shenzhen Component Index closed at 13329.99, up 1.39% [1] - Dazhong Mining's stock price rose by 10.01% to 27.92, with a trading volume of 394,500 shares and a transaction value of 1.051 billion yuan [1] Group 2 - The net inflow of main funds in the steel raw materials sector was 196 million yuan, while retail investors experienced a net outflow of 142 million yuan [1] - Dazhong Mining had a main fund net inflow of 198 million yuan, accounting for 18.84% of its total trading [2] - The overall trend showed that while main funds were entering the sector, retail investors were withdrawing, indicating a divergence in investment behavior [2]

Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]

12月2日晚间，广东明珠集团股份有限公司（600382.SH）发布董事会公告，公司推出三季度现金分红 预案，拟以扣除回购专用账户股份后的股本为基数，每10股派2元现金红利(含税)，合计拟派发现金红 利1.30亿元(含税)，占公司2025年前三季度合并报表中归属于上市公司股东的净利润的比例为55.48%。 广东明珠此次推出前三季度分红方案，核心出发点是回报股东的长期信任与支持，让投资者共享经营发 展成果。公司管理层经过审慎评估，认为当前经营状况和现金流水平足以支撑分红计划，同时也能为后 续经营发展保留充足动力，实现股东回报与企业发展的良性平衡。 在广东明珠看来，稳定的分红政策是企业治理成熟的重要标志。事实上，公司多年来始终保持着积极的 分红传统，此次三季度分红并非偶然之举，而是对这一传统的延续与深化。 从全A市场看，广东明珠的分红行动也与A股市场分红常态化的趋势相契合。政策导向上，监管层近年 来持续鼓励上市公司增强分红稳定性，推动一年多次分红。新"国九条"明确提出强化股东回报机制，证 监会也通过一系列政策构建"激励+约束"的分红生态，据统计，截至10月31日，218家A股公司发布三季 报利润分配方案，合计拟现金 ...

一、董事离任情况 | 是否继续在上 | 具体职 | 是否存在未 | 离任 | 原定任期 | 姓名 | 离任时间 | 离任原因 | 市公司及其控 | 务（如 | 履行完毕的 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 职务 | 到期日 | 股子公司任职 | 适用） | 公开承诺 | | | | | | | | | | | | | | | | 2025 | 年 | 12 | 2028 | 年 | 3 | 月 | 个人原因 | 饶健华 | 董事 | 否 | 无 | 否 | 月 | 1 | 日 | 23 | 日 | 辞职 | (一) 提前离任的基本情况 证券代码：600382 证券简称：广东明珠 公告编号：2025-079 广东明珠集团股份有限公司 关于董事离任暨补选董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性 ...

广东明珠集团股份有限公司 证券代码：600382 证券简称：广东明珠 公告编号：2025-081 关于召开2025年第三次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的 方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 12 月 18 日 14 点 00 分 召开地点：广东省兴宁市官汕路 99 号本公司技术中心大楼二楼会议室 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 12 月 18 日 股东会召开日期：2025年12月18日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 (一) 股东会类型和届次 2025年第三次临时股东会 (二) 股东会召集人：董事会 至2025 年 12 月 18 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为 股东会召开当日 ...

证券简称：广东明珠 证券代码：600382 公告编号：临 2025-078 广东明珠集团股份有限公司 第十一届董事会 2025 年第三次临时会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、董事会会议召开情况 广东明珠集团股份有限公司（以下简称"公司"）第十一届董事会 2025 年第 三次临时会议通知于 2025 年 11 月 28 日以通讯等方式发出，并于 2025 年 12 月 2 日以现场结合通讯方式召开（现场会议地址：广州总部会议室，会议时间：上 午 9:30），根据公司章程及《董事会议事规则》的规定，公司全体与会董事同意 豁免本次会议通知期限。会议应到会董事 6 名，实际到会董事 6 名（其中：出席 现场会议的董事 4 名，以视频通讯方式出席会议的董事 2 名）。会议由董事长黄 丙娣女士主持，公司高级管理人员列席了本次会议，符合《中华人民共和国公司 法》和《公司章程》的有关规定。 会议以记名和书面的方式，审议并通过了如下议案： 1. 关于补选第十一届董事会非独立董事的议案 表决结果：同 ...

●分配比例：每 10 股派 2.00 元现金红利(含税)。 证券代码：600382 证券简称：广东明珠 公告编号：临 2025-080 广东明珠集团股份有限公司 关于公司 2025 年前三季度利润分配方案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 该利润分配方案待 2025 年第三次临时股东会审议通过后实施。以上利润分 配方案符合《公司章程》规定的利润分配政策和公司《三年（2024-2026 年）股 东回报规划》。 ●本次利润分配以实施权益分派股权登记日登记的总股本扣除公司回购专 用账户的股份为基数，具体日期将在权益分派实施公告中明确。 ●如在本公告披露之日起至实施权益分派股权登记日期间，因回购股份等致 使公司总股本和/或有权参与权益分派的股数发生变动的，公司拟维持每股分配 比例不变，相应调整分配总额，并将在相关公告中披露。 ●本次利润分配方案已经公司第十一届董事会 2025 年第三次临时会议审议 通过，尚需提交公司 2025 年第三次临时股东会审议批准方可实施。 一、 2025 年前三季度利润分配 ...

Group 1 - Guangdong Mingzhu's stock price increased by 5.81%, reaching 7.28 CNY per share, with a trading volume of 102 million CNY and a turnover rate of 2.09%, resulting in a total market capitalization of 5.055 billion CNY [1] - Guangdong Mingzhu Group Co., Ltd. is located at No. 99, Guanshan Road, Xingning City, Guangdong Province, established on April 21, 1994, and listed on January 18, 2001. The company's main business involves iron ore mining and the production and sale of iron concentrate [1] Group 2 - From the perspective of the top ten circulating shareholders of Guangdong Mingzhu, a fund under Guotai Fund ranks among the top shareholders. The Guotai CSI Steel ETF (515210) entered the top ten shareholders in the third quarter, holding 4.1525 million shares, accounting for 0.6% of the circulating shares, with an estimated floating profit of approximately 1.661 million CNY today [2] - The Guotai CSI Steel ETF (515210) was established on January 22, 2020, with a current scale of 3.66 billion CNY. Year-to-date return is 26.38%, ranking 1817 out of 4206 in its category; the one-year return is 24.28%, ranking 1806 out of 4012; and since inception, the return is 67.37% [2] - The fund manager of Guotai CSI Steel ETF (515210) is Wu Zhonghao, who has been in the position for 3 years and 310 days, managing total fund assets of 25.391 billion CNY, with the best fund return during his tenure being 73.59% and the worst being -18.06% [2]

（文章来源：证券日报） 证券日报网讯广东明珠11月25日在互动平台回答投资者提问时表示，根据公司2025年《第三季度报 告》，截至2025年9月30日，公司股东人数为18384户。 ...